Literature DB >> 24051058

Effects of TET1 knockdown on gene expression and DNA methylation in porcine induced pluripotent stem cells.

Anran Fan1, Kuiying Ma, Xinglan An, Yu Ding, Peipei An, Guangqi Song, Lina Tang, Sheng Zhang, Peng Zhang, Wentao Tan, Bo Tang, Xueming Zhang, Ziyi Li.   

Abstract

TET1 is implicated in maintaining the pluripotency of embryonic stem cells. However, its precise effects on induced pluripotent stem cells (iPSCs), and particularly on porcine iPSCs (piPSCs), are not well defined. To investigate the role of TET1 in the pluripotency and differentiation of piPSCs, piPSCs were induced from porcine embryonic fibroblasts by overexpression of POU5F1 (OCT4), SOX2, KLF4, and MYC (C-MYC). siRNAs targeting to TET1 were used to transiently knockdown the expression of TET1 in piPSCs. Morphological abnormalities and loss of the undifferentiated state of piPSCs were observed in the piPSCs after the downregulation of TET1. The effects of TET1 knockdown on the expression of key stem cell factors and differentiation markers were analyzed to gain insights into the molecular mechanisms underlying the phenomenon. The results revealed that knockdown of TET1 resulted in the downregulated expression of pluripotency-related genes, such as LEFTY2, KLF2, and SOX2, and the upregulated expression of differentiation-related genes including PITX2, HAND1, GATA6, and LEF1. However, POU5F1, MYC, KLF4, and NANOG were actually not downregulated. Further analysis showed that the methylation levels of the promoters for POU5F1 and MYC increased significantly after TET1 downregulation, whereas there were no obvious changes in the promoters of SOX2, KLF4, and NANOG. The methylation of the whole genome increased, while hydroxymethylation slightly declined. Taken together, these results suggest that TET1 may play important roles in the self-renewal of piPSCs and the maintenance of their characteristics by regulating the expression of genes and the DNA methylation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24051058     DOI: 10.1530/REP-13-0212

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  6 in total

Review 1.  Pluripotent stem cells and livestock genetic engineering.

Authors:  Delia A Soto; Pablo J Ross
Journal:  Transgenic Res       Date:  2016-02-19       Impact factor: 2.788

2.  Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.

Authors:  Y Li; N Hong; A Zhang; W Chen; R-H Wang; X-L Xu; C-X Deng
Journal:  Cell Death Dis       Date:  2014-12-04       Impact factor: 8.469

3.  Efficient generation of mouse ESCs-like pig induced pluripotent stem cells.

Authors:  Qi Gu; Jie Hao; Tang Hai; Jianyu Wang; Yundan Jia; Qingran Kong; Juan Wang; Chunjing Feng; Binghua Xue; Bingteng Xie; Shichao Liu; Jinyu Li; Yilong He; Jialu Sun; Lei Liu; Liu Wang; Zhonghua Liu; Qi Zhou
Journal:  Protein Cell       Date:  2014-05       Impact factor: 14.870

4.  Aberrant hypermethylation of aldehyde dehydrogenase 2 promoter upstream sequence in rats with experimental myocardial infarction.

Authors:  Peng Wang; Cheng Shen; Lei Diao; Zhiyin Yang; Fan Fan; Cong Wang; Xiangwei Liu; Xiaolei Sun; Zhen Dong; Hong Zhu; Xin Ma; Quan Cao; Xiaona Zhao; Duan Ma; Yunzeng Zou; Kai Hu; Aijun Sun; Junbo Ge
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

Review 5.  The use of induced pluripotent stem cells in domestic animals: a narrative review.

Authors:  Rachel A Scarfone; Samantha M Pena; Keith A Russell; Dean H Betts; Thomas G Koch
Journal:  BMC Vet Res       Date:  2020-12-08       Impact factor: 2.741

6.  Transgenerational deep sequencing revealed hypermethylation of hippocampal mGluR1 gene with altered mRNA expression of mGluR5 and mGluR3 associated with behavioral changes in Sprague Dawley rats with history of prolonged febrile seizure.

Authors:  Oluwole Ojo Alese; Musa V Mabandla
Journal:  PLoS One       Date:  2019-11-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.